Eric Topol
Eric Topol
Eric J. Topolis an American cardiologist, geneticist, and digital medicine researcher. Before moving to Scripps in 2006, Topol served as chairman of cardiovascular medicine at Cleveland Clinicand founded the Cleveland Clinic Lerner College of Medicine. Topol was one of the first researchers to question the cardiovascular safety of rofecoxib, culminating in the drug's ultimate withdrawal from the market. Topol's advocacy on the subject led to what the New York Times described as an "unusually public dispute" with the Cleveland Clinic's...
NationalityAmerican
ProfessionScientist
CountryUnited States of America
Of course, the medical profession doesn't like D.I.Y. anything.
They actually were harmed. This was a trial to determine the boundaries of benefit, and it did. You don't use this drug for patients without coronary artery disease.
This is such a big and important medical technology, and there's not a systematic attempt in getting these devices interrogated if a patient dies.
These new data from the Mayo Clinic certainly help support the case for using aspirin before surgery.
My view is that we're not ready for that.
The U.S. government has been preoccupied with health care 'reform,' but this refers to improving access and insurance coverage and has little or nothing to do with innovation.
There has been a series of blatant problems, ... This is the worst situation we've faced in decades at the FDA.
The problem is that it takes physicians so long to accept a radical change. And the lag is unacceptable.
I am prescribing a lot more apps than medications these days.
The digitization of human beings will make a parody out of doctor knows best.
The stethoscope for listening to the heart is over. It's obsolete.
I love information. I can never get enough. I get bored easily.
Warfarin is the drug the medical community loves to hate.
Medicine is incredibly ritualistic.